Garju Pharma SRL
Garju Pharma reported total assets of €1.68m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
By total assets for 2025, Garju Pharma ranks among the 10,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Garju Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +161 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Garju Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
Garju Pharma's financial analysis
- Solvency22.4%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Garju Pharma
Garju Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0782.512.361
- VAT number
- BE0782512361
- Peppol
- Registered · 0208:0782512361 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Feb 2022
- Registered office
- 8793 Waregem
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Garju Pharma (SRL) has been based in Waregem since 2022, active in: business and other management consultancy activities. For 2025, it reports a net profit of 61,923 € and equity of 376,294 €; its revenue is not published. Its solvency stands at 22.4%, below the median of its sector (58.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Garju Pharma
Companies in the same business, of comparable size and area, outside its group.
- Arsaco Business and other management consultancy activities Sint-Pieters-Leeuw · balance sheet €1.54m
- Altesia Group Activities of holding companies Rixensart · balance sheet €1.34m
- C. Consult Activities of holding companies Grobbendonk · balance sheet €1.66m
- L'Aurum Business and other management consultancy activities Hasselt · balance sheet 971,706 €
- Mach Immo Activities of holding companies Zonhoven · balance sheet €1.50m
- Demas - C Activities of holding companies Wervik · balance sheet €1.46m
- Debrafo Business and other management consultancy activities Oostkamp · balance sheet €1.24m
- TripleD Activities of holding companies Willebroek · balance sheet €1.59m
Frequently asked questions about Garju Pharma
What is the revenue of Garju Pharma?
Garju Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Garju Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0782512361 for Garju Pharma, if the company is VAT-registered. Its company number (CBE) is 0782.512.361.
Where is the registered office of Garju Pharma?
According to the CBE register, the registered office of Garju Pharma is in 8793 Waregem.
What is the equity of Garju Pharma?
At the close of the 2025 financial year, the equity of Garju Pharma amounts to 376,294 €, a solvency of 22.4% of total assets.
Who manages Garju Pharma?
The register lists 2 active mandates at Garju Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Garju Pharma within its sector?
By total assets for 2025, Garju Pharma ranks among the 10,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.
The full file of Garju Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →